Major owner of Biocept just declared owning 1,681,000 shares of Biocept

Bridge Lb Ally, a major owner of Biocept, has just filed an initial statement of beneficial ownership where 1,681,000 shares of Biocept were declared. This form is usually filed as a prelude to receiving options or buying company shares, so there may be more to come from Ally. Ally operates out of Hong Kong, . Some additional info was provided as follows:

Ally Bridge LB Healthcare Master Fund Limited (the "Master Fund") directly holds the Common Stock and Warrant. Ally Bridge LB Management Limited ("LB Management") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by vi rtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over the shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any. This Form 3 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. (Continued from Footnote 1) By virtue of the transactions described in that certain statement on Schedule 13D filed on October 20, 2016, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the "Exchange Act"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a "group"; however, neither the filing of this Form 3 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists. The Warrants are exercisable at any time after their original issuance. The Warrants will expire five years from the date of their original issuance.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept: Documents Incorporated By Reference TABLE OF CONTENTS Explanatory Note Part III ItemĀ 10 - April 30, 2018

Auto Refresh